NURO vs. INBS, VAPO, VVOS, PSTV, AVGR, MBOT, VERO, AFIB, TMDIF, and STSS
Should you be buying NeuroMetrix stock or one of its competitors? The main competitors of NeuroMetrix include Intelligent Bio Solutions (INBS), Vapotherm (VAPO), Vivos Therapeutics (VVOS), Plus Therapeutics (PSTV), Avinger (AVGR), Microbot Medical (MBOT), Venus Concept (VERO), Acutus Medical (AFIB), Titan Medical (TMDIF), and Sharps Technology (STSS). These companies are all part of the "surgical & medical instruments" industry.
NeuroMetrix (NASDAQ:NURO) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, community ranking, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.
NeuroMetrix has higher revenue and earnings than Intelligent Bio Solutions. NeuroMetrix is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
In the previous week, NeuroMetrix had 2 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 5 mentions for NeuroMetrix and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.44 beat NeuroMetrix's score of 0.31 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.
NeuroMetrix has a beta of 2.26, suggesting that its share price is 126% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.82, suggesting that its share price is 382% more volatile than the S&P 500.
NeuroMetrix has a net margin of -110.64% compared to Intelligent Bio Solutions' net margin of -544.63%. NeuroMetrix's return on equity of -31.31% beat Intelligent Bio Solutions' return on equity.
19.4% of NeuroMetrix shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 7.3% of NeuroMetrix shares are held by company insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
NeuroMetrix received 284 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.
Summary
NeuroMetrix beats Intelligent Bio Solutions on 9 of the 14 factors compared between the two stocks.
Get NeuroMetrix News Delivered to You Automatically
Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NURO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeuroMetrix Competitors List
Related Companies and Tools
